Intensity Therapeutics, Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.81 | $-1.11 | -37.0% | Miss |
| Q12026 FY2026 | $-1.35 | $-0.96 | +28.9% | Beat |
| Q12026 FY2026 | $-0.06 | — | — | Miss |
Back to INTS overview · INTS holders · INTS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.